Klomipramin Mylan

Clomipramine, the active ingredient in Klomipramin Mylan, is a tricyclic antidepressant presented as an oral tablet for oral use. It is prescribed for major depressive disorder, obsessive‑compulsive disorder, panic disorder, and social anxiety disorder in adult patients, where it helps to improve mood and reduce anxiety by modulating brain neurotransmitters.

GNH USA supplies Klomipramin Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance, through rigorous testing and certification, and reliable delivery.

Clomipramine acts on neurotransmitter pathways associated with mood and anxiety disorders.

Major depressive disorder: alleviates depressive symptoms and improves mood. Obsessive‑compulsive disorder: reduces the frequency and intensity of obsessions and compulsions. Panic disorder: decreases the occurrence and severity of panic attacks. Social anxiety disorder: lessens anxiety in social situations and improves functional performance.

Clomipramine may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Constipation: reduced bowel movements. - Drowsiness: feeling of sleepiness. - Weight gain: increase in body weight.

Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heart rhythm that may be life‑threatening. - Seizures: convulsive episodes requiring immediate medical attention.

When prescribing clomipramine, clinicians should consider several safety measures to minimize risks.

Cardiac monitoring: assess patients with known heart disease for potential arrhythmias. Suicidal ideation assessment: monitor for emergence of suicidal thoughts, especially early in treatment. Discontinuation syndrome: avoid abrupt cessation; taper dose gradually. Hepatic impairment: adjust dosing in patients with liver dysfunction. Drug interactions: review concomitant medications for serotonergic or CYP2D6 inhibitors. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Clomipramine interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: concurrent use can cause serotonin syndrome. - Selective serotonin reuptake inhibitors: increased risk of serotonin syndrome. - CYP2D6 inhibitors (e.g., fluoxetine): may raise clomipramine levels and toxicity. - Other tricyclic antidepressants: additive cardiotoxic effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: heightened bleeding risk. - Antihistamines: may enhance sedation and anticholinergic effects. - Diuretics: can exacerbate orthostatic hypotension. - Alcohol: may increase central nervous system depression.